BIOGEN INC. is 38.8x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($28.73 B vs $740.57 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGEM | BIIB |
|---|---|---|
| Market cap | $740.57 M | $28.73 B |
| US-listed rank | #2664 | #480 |
| Revenue (latest FY) | $0.00 | $9.89B |
| Net income (latest FY) | -$219.88M | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 435 | 2,690 |
BIOGEN INC. is 38.8x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($28.73 B vs $740.57 M).
Full pages: Cullinan Therapeutics, Inc. and BIOGEN INC., or browse the full rankings.